Research with impact
Breakthrough research could prevent sugar-induced liver disease
Fructose causes liver toxicity by changing the barrier function of the intestine, an international team of researchers that includes Monash University academics has found.
Revealed! What really triggers migraines
The molecular events that lead to debilitating migraines that afflict five million Australians every year have always been a mystery … until now.
New ways to treat chronic pain without opioids
Severe neuropathic pain could be treated safely and effectively without the need for potentially harmful opioids.
Antibiotic to fight deadly superbugs enters trials
A game-changing new antibiotic to combat bacterial superbugs has been developed by Monash University researchers.
Beta-blocker could save breast cancer patients
An existing drug that could dramatically reduce the spread of breast cancer and improve survival rates has been identified by a team from Monash Institute of Pharmaceutical Sciences.
New drug to treat alcohol abuse
Targeting a specific receptor in the brain could reduce alcohol addiction, a condition that costs the Australian economy over $14 billion a year. One in six adults drink enough to place them at risk of developing an alcohol-related disease.
Monash awarded $2m for aged care drug safety study
The overreliance on psychotropic medications in aged care facilities is a serious problem, affecting thousands of elderly Australians.
Monash researchers identify potential cause and treatment for obesity and insulin resistance
Monash University researchers have shown for the first time that gut lymphatic dysfunction is a potential cause of and therapeutic target for obesity and insulin resistance.
Departing Ware Fellow delivers verdict on new Pharmacy program
Before she went to university, Dr Kayley Lyons was a self-described quiet nerd who loved maths and science. When she thought about the future, she imagined a secure job that would allow her to stay close to her home in Minnesota. Eighteen years on and she couldn’t be further away from home.
Project Pharmacist concludes: John Jackson looks back
In 2007, John Jackson was the President of the Pharmaceutical Society of Victoria. In that year Professor Bill Charman became Dean of the Faculty of Pharmacy and Pharmaceutical Sciences (then the Victorian College of Pharmacy). In their first meeting, Jackson told Charman that he had a significant concern about the state of pharmacy in Australia.